Evidence map›Paper›PMID 29392180›Full record

ArticleACS central science2018

REDOR NMR Reveals Multiple Conformers for a Protein Kinase C Ligand in a Membrane Environment.

Hao Yang, Daryl Staveness, Steven M Ryckbosch, Alison D Axtman, Brian A Loy, Alexander B Barnes, Vijay S Pande, Jacob Schaefer, Paul A Wender, Lynette Cegelski

Open access · diamondAbstract read
In one paragraph

Article in ACS central science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Ingenane Diterpenoids fromMolecules (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Tigliane Diterpenoids.Progress in the chemistry of organic natural products · 2024
    Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Solid-state NMR spectroscopy.Nature reviews. Methods primers · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. High-Sensitivity Detection of NanometerThe journal of physical chemistry. B · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Hao YangDepartment of Chemistry, Washington University in St. Louis, St. Louis, Missouri 63130, United States.
Daryl StavenessDepartment of Chemistry, Stanford University, Stanford, California 94305, United States.
Steven M RyckboschDepartment of Chemistry, Stanford University, Stanford, California 94305, United States.
Alison D AxtmanDepartment of Chemistry, Stanford University, Stanford, California 94305, United States.
Brian A LoyDepartment of Chemistry, Stanford University, Stanford, California 94305, United States.
Alexander B BarnesDepartment of Chemistry, Washington University in St. Louis, St. Louis, Missouri 63130, United States.
Vijay S PandeDepartment of Chemistry, Stanford University, Stanford, California 94305, United States.
Jacob SchaeferDepartment of Chemistry, Washington University in St. Louis, St. Louis, Missouri 63130, United States.
Paul A WenderDepartment of Chemistry, Stanford University, Stanford, California 94305, United States.
Lynette CegelskiDepartment of Chemistry, Stanford University, Stanford, California 94305, United States.
Stanford University · USWashington University in St. Louis · US

Funding

SYNTHETIC STUDIES RELATED TO CANCER RESEARCH/TREATMENTR01CA031845 · NCI · STANFORD UNIVERSITY · PI PAUL Anthony WENDER · 1985 to 2026
$6.9M
Bacterial Cell Wall Composition and the Influence of AntibioticsR01GM117278 · NIGMS · STANFORD UNIVERSITY · PI CEGELSKI, LYNETTE S · 2016 to 2023
$2.6M
NCI NIH HHS R01 CA031845NIGMS NIH HHS R01 GM117278
6 · The paper itself

Abstract

Bryostatin 1 (henceforth bryostatin) is in clinical trials for the treatment of Alzheimer's disease and for HIV/AIDS eradication. It is also a preclinical lead for cancer immunotherapy and other therapeutic indications. Yet nothing is known about the conformation of bryostatin bound to its protein kinase C (PKC) target in a membrane microenvironment. As a result, efforts to design more efficacious, better tolerated, or more synthetically accessible ligands have been limited to structures that do not include PKC or membrane effects known to influence PKC-ligand binding. This problem extends more generally to many membrane-associated proteins in the human proteome. Here, we use rotational-echo double-resonance (REDOR) solid-state NMR to determine the conformations of PKC modulators bound to the PKCδ-C1b domain in the presence of phospholipid vesicles. The conformationally limited PKC modulator phorbol diacetate (PDAc) is used as an initial test substrate. While unanticipated partitioning of PDAc between an immobilized protein-bound state and a mobile state in the phospholipid assembly was observed, a single conformation in the bound state was identified. In striking contrast, a bryostatin analogue (bryolog) was found to exist exclusively in a protein-bound state, but adopts a distribution of conformations as defined by three independent distance measurements. The detection of multiple PKCδ-C1b-bound bryolog conformers in a functionally relevant phospholipid complex reveals the inherent dynamic nature of cellular systems that is not captured with single-conformation static structures. These results indicate that binding, selectivity, and function of PKC modulators, as well as the design of new modulators, are best addressed using a dynamic multistate model, an analysis potentially applicable to other membrane-associated proteins.

Identifiers

PMID29392180
PMCPMC5785774
OpenAlexW2781828200

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.